nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromhexine—Vomiting—Altretamine—ovarian cancer	0.0295	0.0295	CcSEcCtD
Bromhexine—Nausea—Altretamine—ovarian cancer	0.0276	0.0276	CcSEcCtD
Bromhexine—Bronchospasm—Melphalan—ovarian cancer	0.0249	0.0249	CcSEcCtD
Bromhexine—Bronchospasm—Vinorelbine—ovarian cancer	0.0217	0.0217	CcSEcCtD
Bromhexine—Immune system disorder—Topotecan—ovarian cancer	0.0187	0.0187	CcSEcCtD
Bromhexine—Angioedema—Chlorambucil—ovarian cancer	0.0185	0.0185	CcSEcCtD
Bromhexine—Immune system disorder—Melphalan—ovarian cancer	0.0183	0.0183	CcSEcCtD
Bromhexine—Angioedema—Topotecan—ovarian cancer	0.0164	0.0164	CcSEcCtD
Bromhexine—Immune system disorder—Vinorelbine—ovarian cancer	0.016	0.016	CcSEcCtD
Bromhexine—Abdominal pain upper—Paclitaxel—ovarian cancer	0.0157	0.0157	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.0152	0.0152	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.0149	0.0149	CcSEcCtD
Bromhexine—Anaphylactic shock—Topotecan—ovarian cancer	0.0147	0.0147	CcSEcCtD
Bromhexine—Anaphylactic shock—Melphalan—ovarian cancer	0.0144	0.0144	CcSEcCtD
Bromhexine—Skin disorder—Topotecan—ovarian cancer	0.0143	0.0143	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.0142	0.0142	CcSEcCtD
Bromhexine—Angioedema—Vinorelbine—ovarian cancer	0.0141	0.0141	CcSEcCtD
Bromhexine—Skin disorder—Melphalan—ovarian cancer	0.014	0.014	CcSEcCtD
Bromhexine—Abdominal pain upper—Docetaxel—ovarian cancer	0.0133	0.0133	CcSEcCtD
Bromhexine—Urticaria—Chlorambucil—ovarian cancer	0.0131	0.0131	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.013	0.013	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.0127	0.0127	CcSEcCtD
Bromhexine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.0126	0.0126	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.0124	0.0124	CcSEcCtD
Bromhexine—Bronchospasm—Docetaxel—ovarian cancer	0.0124	0.0124	CcSEcCtD
Bromhexine—Skin disorder—Vinorelbine—ovarian cancer	0.0122	0.0122	CcSEcCtD
Bromhexine—Hypersensitivity—Chlorambucil—ovarian cancer	0.0122	0.0122	CcSEcCtD
Bromhexine—Pruritus—Chlorambucil—ovarian cancer	0.0117	0.0117	CcSEcCtD
Bromhexine—Urticaria—Topotecan—ovarian cancer	0.0117	0.0117	CcSEcCtD
Bromhexine—Urticaria—Melphalan—ovarian cancer	0.0114	0.0114	CcSEcCtD
Bromhexine—Diarrhoea—Chlorambucil—ovarian cancer	0.0113	0.0113	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.0108	0.0108	CcSEcCtD
Bromhexine—Hypersensitivity—Topotecan—ovarian cancer	0.0108	0.0108	CcSEcCtD
Bromhexine—Immune system disorder—Paclitaxel—ovarian cancer	0.0107	0.0107	CcSEcCtD
Bromhexine—Hypersensitivity—Melphalan—ovarian cancer	0.0106	0.0106	CcSEcCtD
Bromhexine—Vomiting—Chlorambucil—ovarian cancer	0.0105	0.0105	CcSEcCtD
Bromhexine—Pruritus—Topotecan—ovarian cancer	0.0104	0.0104	CcSEcCtD
Bromhexine—Pruritus—Melphalan—ovarian cancer	0.0102	0.0102	CcSEcCtD
Bromhexine—Diarrhoea—Topotecan—ovarian cancer	0.01	0.01	CcSEcCtD
Bromhexine—Urticaria—Vinorelbine—ovarian cancer	0.00998	0.00998	CcSEcCtD
Bromhexine—Diarrhoea—Melphalan—ovarian cancer	0.00984	0.00984	CcSEcCtD
Bromhexine—Nausea—Chlorambucil—ovarian cancer	0.0098	0.0098	CcSEcCtD
Bromhexine—Angioedema—Paclitaxel—ovarian cancer	0.00946	0.00946	CcSEcCtD
Bromhexine—Vomiting—Topotecan—ovarian cancer	0.00934	0.00934	CcSEcCtD
Bromhexine—Rash—Topotecan—ovarian cancer	0.00926	0.00926	CcSEcCtD
Bromhexine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00925	0.00925	CcSEcCtD
Bromhexine—Dermatitis—Topotecan—ovarian cancer	0.00925	0.00925	CcSEcCtD
Bromhexine—Vomiting—Melphalan—ovarian cancer	0.00914	0.00914	CcSEcCtD
Bromhexine—Immune system disorder—Docetaxel—ovarian cancer	0.0091	0.0091	CcSEcCtD
Bromhexine—Rash—Melphalan—ovarian cancer	0.00906	0.00906	CcSEcCtD
Bromhexine—Dermatitis—Melphalan—ovarian cancer	0.00906	0.00906	CcSEcCtD
Bromhexine—Abdominal pain upper—Epirubicin—ovarian cancer	0.00898	0.00898	CcSEcCtD
Bromhexine—Pruritus—Vinorelbine—ovarian cancer	0.00889	0.00889	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00875	0.00875	CcSEcCtD
Bromhexine—Nausea—Topotecan—ovarian cancer	0.00872	0.00872	CcSEcCtD
Bromhexine—Diarrhoea—Vinorelbine—ovarian cancer	0.00859	0.00859	CcSEcCtD
Bromhexine—Nausea—Melphalan—ovarian cancer	0.00854	0.00854	CcSEcCtD
Bromhexine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00845	0.00845	CcSEcCtD
Bromhexine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.0083	0.0083	CcSEcCtD
Bromhexine—Skin disorder—Paclitaxel—ovarian cancer	0.00821	0.00821	CcSEcCtD
Bromhexine—Vomiting—Vinorelbine—ovarian cancer	0.00799	0.00799	CcSEcCtD
Bromhexine—Rash—Vinorelbine—ovarian cancer	0.00792	0.00792	CcSEcCtD
Bromhexine—Dermatitis—Vinorelbine—ovarian cancer	0.00791	0.00791	CcSEcCtD
Bromhexine—Nausea—Vinorelbine—ovarian cancer	0.00746	0.00746	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00742	0.00742	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00729	0.00729	CcSEcCtD
Bromhexine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00716	0.00716	CcSEcCtD
Bromhexine—Skin disorder—Docetaxel—ovarian cancer	0.00696	0.00696	CcSEcCtD
Bromhexine—Urticaria—Paclitaxel—ovarian cancer	0.00671	0.00671	CcSEcCtD
Bromhexine—Hypersensitivity—Paclitaxel—ovarian cancer	0.00622	0.00622	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00618	0.00618	CcSEcCtD
Bromhexine—Immune system disorder—Epirubicin—ovarian cancer	0.00614	0.00614	CcSEcCtD
Bromhexine—Pruritus—Paclitaxel—ovarian cancer	0.00598	0.00598	CcSEcCtD
Bromhexine—Diarrhoea—Paclitaxel—ovarian cancer	0.00578	0.00578	CcSEcCtD
Bromhexine—Immune system disorder—Doxorubicin—ovarian cancer	0.00568	0.00568	CcSEcCtD
Bromhexine—Vomiting—Paclitaxel—ovarian cancer	0.00537	0.00537	CcSEcCtD
Bromhexine—Rash—Paclitaxel—ovarian cancer	0.00533	0.00533	CcSEcCtD
Bromhexine—Dermatitis—Paclitaxel—ovarian cancer	0.00532	0.00532	CcSEcCtD
Bromhexine—Hypersensitivity—Docetaxel—ovarian cancer	0.00528	0.00528	CcSEcCtD
Bromhexine—Pruritus—Docetaxel—ovarian cancer	0.00507	0.00507	CcSEcCtD
Bromhexine—Nausea—Paclitaxel—ovarian cancer	0.00502	0.00502	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.005	0.005	CcSEcCtD
Bromhexine—Diarrhoea—Docetaxel—ovarian cancer	0.0049	0.0049	CcSEcCtD
Bromhexine—Anaphylactic shock—Epirubicin—ovarian cancer	0.00483	0.00483	CcSEcCtD
Bromhexine—Skin disorder—Epirubicin—ovarian cancer	0.00469	0.00469	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00463	0.00463	CcSEcCtD
Bromhexine—Vomiting—Docetaxel—ovarian cancer	0.00455	0.00455	CcSEcCtD
Bromhexine—Rash—Docetaxel—ovarian cancer	0.00452	0.00452	CcSEcCtD
Bromhexine—Dermatitis—Docetaxel—ovarian cancer	0.00451	0.00451	CcSEcCtD
Bromhexine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00447	0.00447	CcSEcCtD
Bromhexine—Skin disorder—Doxorubicin—ovarian cancer	0.00434	0.00434	CcSEcCtD
Bromhexine—Nausea—Docetaxel—ovarian cancer	0.00425	0.00425	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00417	0.00417	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00386	0.00386	CcSEcCtD
Bromhexine—Urticaria—Epirubicin—ovarian cancer	0.00384	0.00384	CcSEcCtD
Bromhexine—Hypersensitivity—Epirubicin—ovarian cancer	0.00356	0.00356	CcSEcCtD
Bromhexine—Urticaria—Doxorubicin—ovarian cancer	0.00355	0.00355	CcSEcCtD
Bromhexine—Pruritus—Epirubicin—ovarian cancer	0.00342	0.00342	CcSEcCtD
Bromhexine—Diarrhoea—Epirubicin—ovarian cancer	0.0033	0.0033	CcSEcCtD
Bromhexine—Hypersensitivity—Doxorubicin—ovarian cancer	0.00329	0.00329	CcSEcCtD
Bromhexine—Pruritus—Doxorubicin—ovarian cancer	0.00316	0.00316	CcSEcCtD
Bromhexine—Vomiting—Epirubicin—ovarian cancer	0.00307	0.00307	CcSEcCtD
Bromhexine—Diarrhoea—Doxorubicin—ovarian cancer	0.00306	0.00306	CcSEcCtD
Bromhexine—Rash—Epirubicin—ovarian cancer	0.00305	0.00305	CcSEcCtD
Bromhexine—Dermatitis—Epirubicin—ovarian cancer	0.00304	0.00304	CcSEcCtD
Bromhexine—Nausea—Epirubicin—ovarian cancer	0.00287	0.00287	CcSEcCtD
Bromhexine—Vomiting—Doxorubicin—ovarian cancer	0.00284	0.00284	CcSEcCtD
Bromhexine—Rash—Doxorubicin—ovarian cancer	0.00282	0.00282	CcSEcCtD
Bromhexine—Dermatitis—Doxorubicin—ovarian cancer	0.00282	0.00282	CcSEcCtD
Bromhexine—Nausea—Doxorubicin—ovarian cancer	0.00265	0.00265	CcSEcCtD
